Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1245823-50-0
1286281-32-0
1446282-18-3
149577-05-9
1818294-42-6
209542-49-4
2183440-33-5 | Methyltetrazine-peg8-acid | AA019EES | MFCD31580146
1363404-73-2 | Octahydro-2H-pyrano[3,2-c]pyridine hydrochloride | AA019EIF | MFCD21607362
169295-54-9 | 2,2,2-Trifluoro-1-(4-Methoxy-naphthalen-1-yl)-ethanone | AA019ELE | MFCD07380807
349404-68-8 | 4-bromo-N-(3,4-dimethylphenyl)benzenesulfonamide | AA019EOH | MFCD18384736
1034470-00-2 | Ethyl 3-amino-4-cyanobenzoate | AA019ERX | MFCD20702986
1284226-15-8 | Ethyl 2-(trifluoromethyl)indolizine-1-carboxylate | AA019EV0 | MFCD08447583
1462849-54-2 | 2-Methyl-3-(piperidin-4-yl)pyridine dihydrochloride | AA019EYA | MFCD29075594
12192-57-3 | Aurothioglucose | AA019FQK | MFCD00056080
51453-79-3 | Ethyl4-azidobutyrate-E3898 | AA019G3P | MFCD24452387
329268-45-3 | 3-(3,4-Difluoro-benzenesulfonylamino)-benzoic acid | AA019GHU | MFCD02709723